Skip to Main Content

Paper Details

Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.
Am J Hematol
0
2023
Author NameAffiliation
Christopher I AmosInstitute for Clinical & Translational Research, Baylor College of Medicine
Christopher I AmosBaylor College of Medicine
Christopher I AmosInstitute for Clinical & Translational Research, Baylor College of Medicine
Christopher I AmosBaylor College of Medicine
John Michael GazianoVA Boston Healthcare System
John Michael GazianoHarvard Medical School
John Michael GazianoVA Boston Healthcare System
John Michael GazianoHarvard Medical School
  • 1 - 8

Datasets

Release 1.2